Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, September 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Product Launches at Lab Innovations 2013
Tuesday, October 01, 2013
Over 40% of exhibitors at Lab Innovations 2013 are using the show to launch new technologies and services into the UK.

A New Generation Screening Collection (AXXDIV2.0) is Now Available for Drug Discovery Programs
Thursday, September 26, 2013
Axxam S.p.A. announced that an entirely new generation screening collection is now available for drug discovery programs: AXXDIV2.0 made up with 240,000 carefully selected small molecules.

Fast & Precise Biomass Analysis Tool
Friday, September 13, 2013
The Model 440 Elemental Analyzer analyze a sample in 6 minutes.

Hepregen Launches First Rat HepatoPac™ DMPK Assay Kits
Thursday, September 12, 2013
Companions to recently introduced human HepatoPac™ DMPK application-oriented kit.

Robot-Compatible Automatic Dry Down Station
Tuesday, September 10, 2013
Porvair will launch UltraVap Mistral at Biotechnica 2013.

Faster Drying of Deep Well Microplates
Tuesday, September 10, 2013
New generation heat transfer plates from Genevac.

Large Volume Plates for Storage / Transport Applications
Thursday, August 22, 2013
Available in sterile or non-sterile versions.

Highly Affordable Lab Safety Shield
Wednesday, August 21, 2013
Provides protection for chemists from draughts, splashes, aerosols and spills.

Evaporation Chemistry at ACS
Monday, August 19, 2013
Genevac to display its latest products for productive evaporation in USA.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1263
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv